Publications

Filtrer

2025

Peritoneal surface malignancy: performing complete cytoreduction in occult peritoneal spaces is challenging

Affiliations Expand PMID: 40560099 DOI: 10.1093/bjs/znaf098

2025

Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundaries

Affiliations Expand PMID: 40560096 DOI: 10.1093/bjs/znaf099

2024

[Real-life evaluation of the care pathway of patients eligible for axicabtagene ciloleucel treatment: Analysis of a multicenter retrospective cohort (IMPA-CT study)].

Cartron G, Thieblemont C, Borget I, Rioufol C, Berthet M, Portal C, Baujat C, Alaoui E, Baffert S, Lacroix D, Bories P, Yakoub-Agha I, Houot R.

Bull Cancer. 2024 Nov;111(11):1020-1029. doi: 10.1016/j.bulcan.2024.07.010. Epub 2024 Sep 11.PMID: 39266425 French.

2024

The Significance of the Morphological Appearance of Peritoneal Lesions on Imaging in Patients With Peritoneal Malignancies-A Report From Phase 1 of the PRECINCT Study.

Bhatt A, Rousset P, Moran BJ, Kazi M, Baratti D, Souadka A, Deraco M, Sammartino P, Sardi A, Glehen O; PRECINCT Study Group.

J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27869. Online ahead of print.PMID: 39295553

2024

Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis

Elea Vachez, Amaniel Kefleyesus, Naoual Bakrin, Florence Ranchon, Catherine Rioufol, Olivia Vassal, Omar Al-Hadeedi, Vahan Kepenekian, Olivier Glehen 

Affiliations Expand PMID: 38219699 DOI: 10.1016/j.ejso.2024.107955

2024

Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients.

Bouvarel B, Colomban O, Frenel JS, Loaec C, Bourgin C, Berton D, Freyer G, You B, Classe JM.

Int J Gynecol Cancer. 2024 Apr 1;34(4):574-580. doi: 10.1136/ijgc-2023-004872.PMID: 38242546

2024

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Freyer G, Floquet A, Tredan O, Carrot A, Langlois-Jacques C, Lopez J, Selle F, Abdeddaim C, Leary A, Dubot-Poitelon C, Fabbro M, Gladieff L, Lamuraglia M.

Nat Commun. 2024 Mar 5;15(1):1985. doi: 10.1038/s41467-024-45974-w.PMID: 38443333 

2024

Visceral artery pseudoaneurysm: predictive factors for clinical success after transarterial embolization.

Grange R, Habouzit V, Stacoffe N, Magand N, Williet N, Le Roy B, Boutet C, Grange S.

Quant Imaging Med Surg. 2024 Sep 1;14(9):6436-6448. doi: 10.21037/qims-24-463. Epub 2024 Aug 7.PMID: 39281180 

2024

Clinical impact and cost-saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer.

Herledan C, Falandry C, Huot L, Poletto N, Baudouin A, Cerfon MA, Lorsche L, Bret J, Ranchon F, Rioufol C.

J Am Geriatr Soc. 2024 Feb;72(2):567-578. doi: 10.1111/jgs.18585. Epub 2023 Oct 11.PMID: 37818698

2024

Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Katz SI, Frauenfelder T, Jayasekera G, Catino A, Blyth KG, Theodoro T, Rousset P, Nackaerts K, Opitz I.

Lung Cancer. 2024 Jul;193:107832. doi: 10.1016/j.lungcan.2024.107832. Epub 2024 May 31.PMID: 38875938 

2024

PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial

Frédéric Dumont, Vahan Kepenekian, Christophe Passot, Anne-Cécile Ezanno-Manasterski, Marc Pocard, Jean-Luc Raoul, Bénédicte Lelièvre, Sandrine Hiret, Hélène Senellart, Francois Pein, Judith Raimbourg, Loic Campion, Emilie Thibaudeau, Julie Paul, Olivier Glehen 

BIG-RENAPE Networks Affiliations Expand PMID: 38878757 DOI: 10.1016/j.ejso.2024.108468